Rocket Lab CFO exercises options, sells 140K shares
Rocket Lab’s CFO exercised stock options and sold an equal number of shares under a pre-arranged Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
Rocket Lab Corp (RKLB) reported that Chief Financial Officer Adam C. Spice exercised employee stock options and sold common shares on September 2, 2026. He exercised options for 140,157 shares of common stock at an exercise price of $1.09 per share, then sold the same number of shares in open-market transactions under a Rule 10b5-1 trading plan adopted on June 3, 2026.
The sales comprised 67,257 shares at a weighted-average price of about $62.26 per share within a range of $61.59 to $62.58, and 72,900 shares at a weighted-average price of about $62.97 per share within a range of $62.59 to $63.47. Following the option exercise, Spice held 2,382,668 stock options, and a separate trust associated with him held 250,000 shares of common stock indirectly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 140,157 shares ($8.62M approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Spice Adam C.
Role
Chief Financial Officer
Sold
140,157 shs ($8.78M)
Approx. gross sale proceeds
$8.78M
Approx. exercise cost
$153K
Approx. pre-tax spread
$8.62M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F4 | 140,157 | $0.00 | $0.00 |
| Exercise | Common Stock | 140,157 | $1.09 | $153K |
| Sale | Common Stock F1, F2 | 67,257 | $62.2564 | $4.19M |
| Sale | Common Stock F1, F3 | 72,900 | $62.9704 | $4.59M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 2,382,668 contracts (Direct);
Common Stock — 1,155,967 shares (Direct);
Common Stock — 250,000 shares (Indirect, by Trust)
Footnotes (4)
- F1. Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 03, 2026.
- F2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $61.5900 to $62.5800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $62.5900 to $63.4700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The stock option was granted on August 3, 2018, and had a vesting commencement date of May 25, 2018. 1/4 of the shares subject to the stock option vest on the one year anniversary of the vesting commencement date, and 1/48 of the shares subject to the stock option vest on a monthly basis each month thereafter, subject, in each case, to the reporting person's continued service relationship through each applicable vesting date.
Key Figures
Options exercised: 140,157 shares
Option exercise price: $1.09 per share
Shares sold in first sale: 67,257 shares
+3 more
6 metrics
Options exercised
140,157 shares
Employee stock options exercised into Rocket Lab common stock on September 2, 2026
Option exercise price
$1.09 per share
Exercise price for the 140,157 shares of common stock acquired on September 2, 2026
Shares sold in first sale
67,257 shares
Common stock sold on September 2, 2026 at a weighted-average price around $62.26 within a range of $61.59–$62.58
Shares sold in second sale
72,900 shares
Common stock sold on September 2, 2026 at a weighted-average price around $62.97 within a range of $62.59–$63.47
Options held after exercise
2,382,668 options
Total employee stock options reported as held directly by the CFO after the September 2, 2026 exercise
Indirect trust holdings
250,000 shares
Rocket Lab common stock held indirectly by a trust associated with the CFO as of the reporting date
Key Terms
Rule 10b5-1 trading plan, weighted-average price, vesting commencement date, stock option
4 terms
Rule 10b5-1 trading plan regulatory
"Represents the sale of shares which occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 03, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
vesting commencement date financial
"The stock option was granted on August 3, 2018, and had a vesting commencement date of May 25, 2018."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
stock option financial
"The stock option was granted on August 3, 2018, and had a vesting commencement date of May 25, 2018."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
What did Rocket Lab (RKLB) disclose about the CFO’s recent stock option exercise?
Rocket Lab disclosed that CFO Adam C. Spice exercised employee stock options for 140,157 shares of common stock on September 2, 2026 at an exercise price of $1.09 per share, converting those options into newly acquired common shares.
What Rocket Lab (RKLB) stock option holdings does the CFO report after these transactions?
After exercising options on September 2, 2026, the CFO reported holding 2,382,668 employee stock options. These options relate to Rocket Lab common stock and have an expiration date of August 3, 2028, according to the filing’s derivative transaction entry.
What are the price ranges cited for the Rocket Lab (RKLB) CFO’s stock sales?
For 67,257 shares, the filing reports a weighted-average price with sales between $61.59 and $62.58 per share. For 72,900 shares, it reports a weighted-average price with sales between $62.59 and $63.47 per share, and offers to provide detailed breakdowns upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.
